Physician profile
Matthew Grimm
NPI 1407806748
$993.32
in general payments reported to CMS, 2019-2025
16 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $307 · 2020: $106 · 2021: $193 · 2022: $219 · 2023: $28.33 · 2024: $142.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $170.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $169.83 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Horizon Therapeutics Plc | $139.22 | 2019-2020 | |
| Abbott Laboratories | $133.50 | 2019-2024 | Eterna, Proclaim |
| Fidia Pharma USA INC. | $121.07 | 2021-2024 | Hyalgan, Triluron, Hymovis |
| Ferring Pharmaceuticals INC. | $117.49 | 2019-2021 | |
| Davol INC. | $116.30 | 2022 | |
| Pacira Therapeutics, INC. | $82.67 | 2019-2020 | |
| Depuy Synthes Sales INC. | $70.40 | 2020-2024 | Monovisc |
| Stryker Corporation | $70.20 | 2022 | |
| Boston Scientific Corporation | $28.15 | 2019 | |
| Vericel Corporation | $19.73 | 2021 | |
| Sanofi-Aventis U.S. LLC | $19.16 | 2022 | |
| Ethicon US, LLC | $17.25 | 2019 | |
| Polynovo North America LLC | $16.40 | 2019 | |
| Zyla Life Sciences, INC. | $14.32 | 2019 | |
| Abbvie INC. | $14.24 | 2021 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Radius Health, INC. | $13.22 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Matthew Grimm listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.